REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 1.54 billion by 2030 | 13.9% | North America |
By Component | By Deployment Type | By End User |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Infection Surveillance Solutions Market Overview
Infection surveillance solutions market is expected to grow at 13.9% CAGR from 2023 to 2030. It is expected to reach above USD 1.54 billion by 2030.
The infection surveillance solutions market is expected to grow at 13.9% CAGR from 2023 to 2030. It was valued at 0.62 billion in 2023. It is expected to reach above USD 1.54 billion by 2030. The global infection surveillance solutions market is being driven by a number of key factors, including an increase in the incidence of HAIs, an increase in the number of surgeries, the introduction of government protocols for the prevention of HAIs, an increase in global healthcare expenditure, the ease of use of the software system, and advancements in the healthcare insurance sectors.
Software called an infection surveillance system helps hospitals and other healthcare facilities submit patient data to local, state, and federal authorities. This program notifies hospital Internet Protocols (IPs) in the event of an infection so that HAI experts and nurses can treat patients who are infected in order to prevent infection epidemics. These solutions are used to evaluate preventive measures and identify illnesses. They are also required to diagnose antibiotic-resistant organisms and prevent infections brought on by non-sanitized medical equipment.
Accurate employee health data, surgical databases, and real-time medical records are some of these systems’ benefits for healthcare facilities. Surveillance methods are employed to control infection patterns. The market is expanding thanks to the improved analytics capabilities of IT systems. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for managing real-time pharmacy and storing electronic medical records.
Systems for infection surveillance are created to continuously track and examine health-related data to make sure that preventive actions are properly put into practice. Hospital-acquired illnesses, also known as nosocomial infections, are brought on by unsanitary environments, carelessness, the patient’s weakened immune system, the invasion of germs that are resistant to drugs, and practices that can reduce the effectiveness of ongoing therapies.
The market for infection surveillance solutions is growing as hospital-associated infections (HAIs) are becoming more common. Due to contaminated devices and equipment, bed linens and patient apparel, among other things, hospital-associated infections in a clinical context, such as surgical site infections, urinary tract infections, and pneumonia, are on the rise. In order to detect potential healthcare-associated illnesses during patient stays in hospitals and to evaluate preventive measures, healthcare workers and hospitals are now using infection-monitoring systems.
These infections monitoring methods can also be utilized to diagnose infections brought on by non-sanitized medical devices and antibiotic-resistant organisms (AROs). Because of the collection and correlation of antibiotic susceptibility test results with geographical and clinical information for patient populations from whom microorganisms were isolated, an epidemic can be identified and the appropriate formulations can be facilitated. The employment of algorithms with electronic medical records, specialized data mining tools, and fully automated HAI surveillance through the use of clinical support-based data that helps in the detection of particular clinical terms are some of these methods.
Also, due to improvements in IT infrastructure, businesses in the infection surveillance solution market have a huge chance. The creation of analytical and infection surveillance solutions for use in the healthcare sector is being made easier by the increased analytical processing capability of IT systems and technological advancements in IT systems.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion, Thousand Units) |
Segmentation | By Component, By Deployment Type, By End User |
By Component |
|
By Deployment Type |
|
By End User |
|
By Region |
|
Infection Surveillance Solutions Market Segment Analysis
By component the market is segmented into software, services.
A rise in the use of software solutions and related services has contributed to the expansion of the market due to the rising need for infection control and prevention as well as the requirement for better data management and analytics. Additionally, automated infection monitoring and reporting at healthcare facilities improves patient outcomes and lowers healthcare expenditures.
By deployment type the market is segmented into on-premises, cloud-based. Growth of the market is also impacted by choosing between on-premises and cloud-based deployment strategies for infection surveillance solutions. Cloud-based solutions offer scalability, cost-effectiveness, and simplicity of access, which makes them a more popular option, particularly among smaller healthcare facilities and propels market growth while on-premises solutions offer greater control and security.
By end user, the market is segmented into hospitals, clinics, ambulatory service centers, specialty centers, and others. A wide range of healthcare organizations, including hospitals, clinics, ambulatory service centers, speciality centers, and others, are served by the market for infection surveillance solutions. Regulation requirements and rising patient demand have increased the need for infection control and prevention in these institutions, which has increased acceptance of these solutions and fueled the market expansion. Further propelling market expansion is the growing trend towards integrated healthcare systems, which is also anticipated to increase demand for infection surveillance solutions in a variety of healthcare settings.
Infection Surveillance Solutions Market Key Players
Infection surveillance solutions market key players include Baxter International Inc., RL Solutions, Truven Health Analytics (An IBM Company), DEB Group Ltd., Hygreen, Inc., Atlas Medical Software, Becton, Dickinson and Company, Premier Inc., Wolters Kluwer N.V., Gojo Industries, Inc.
April 04, 2023: Â Baxter Launched Zosyn Premix In the US.
March 23, 2021: Wolters Kluwer launched telemedicine resources to help clinicians provide more patient-centered virtual care.
Who Should Buy? Or Key stakeholders
- Healthcare providers
- Healthcare IT companies
- Regulatory authorities
- Patients
- Insurance companies
- Research institutions
- Non-governmental organizations (NGOs)
- Investors
- End users
- Government agencies
- Others
Infection Surveillance Solutions Market Regional Analysis
The infection surveillance solutions market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
With the US being the largest market in the region, North America is one of the main regions for the market for infection surveillance solutions. Numerous factors, such as the rising incidence of infections linked to healthcare, the rising demand for infection control and prevention, and the presence of a strong healthcare infrastructure, are fueling the market growth in North America. The adoption of infection surveillance solutions in healthcare institutions has also been aided by the region’s strict regulatory environment, which includes requirements for the mandatory reporting of healthcare-associated infections and the implementation of antimicrobial stewardship programs. The market for infection surveillance solutions in North America is also anticipated to develop as a result of the rising trend towards the use of healthcare IT solutions, the presence of major industry players, and the growing emphasis on patient safety and quality of treatment.
The market for infection surveillance solutions is one of those that is expanding the fastest in the Asia Pacific area. Numerous reasons, such as the rising incidence of infectious diseases, the rising demand for healthcare services, and the expanding demand for infection control and preventive methods, are fueling market growth in the area. In addition, the region’s dense population, rising government healthcare spending, and rising awareness among healthcare professionals of the advantages of infection surveillance solutions are all fostering market expansion. Additionally, market players in the region may benefit from considerable development potential due to the expanding focus on patient safety and quality of care, the adoption of healthcare IT solutions, and the presence of emerging economies like China and India.
Key Market Segments: Infection Surveillance Solutions Market
Infection Surveillance Solutions Market By Component, 2020-2030, (USD Billion, Thousand Units)
- Software
- Services
Infection Surveillance Solutions Market By Deployment Type, 2020-2030, (USD Billion, Thousand Units)
- On-Premises
- Cloud-Based
Infection Surveillance Solutions Market By End User, 2020-2030, (USD Billion, Thousand Units)
- Hospitals
- Clinics
- Ambulatory Service Centers
- Specialty Centers
- Others
Infection Surveillance Solutions Market By Region, 2020-2030, (USD Billion, Thousand Units)
- North America
- Asia Pacific
- Europe
- South America
- Middle East And Africa
 Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the infection surveillance solutions market over the next 7 years?
- Who are the major players in the infection surveillance solutions market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, the middle east, and Africa?
- How is the economic environment affecting the infection surveillance solutions market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the infection surveillance solutions market?
- What is the current and forecasted size and growth rate of the global infection surveillance solutions market?
- What are the key drivers of growth in the infection surveillance solutions market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the infection surveillance solutions market?
- What are the technological advancements and innovations in the infection surveillance solutions market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the infection surveillance solutions market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the infection surveillance solutions market?
- What are the product voltage ratings and specifications of leading players in the market?
- What is the pricing trend of infection surveillance solutions market in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON INFECTION SURVEILLANCE SOLUTIONS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET OUTLOOK
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION, THOUSAND UNITS), 2020-2030
- SOFTWARE
- SERVICES
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION, THOUSAND UNITS), 2020-2030
- ON-PREMISES
- CLOUD-BASED
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION, THOUSAND UNITS), 2020-2030
- HOSPITALS
- CLINICS
- AMBULATORY SERVICE CENTERS
- SPECIALTY CENTERS
- OTHERS
- GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY REGION (USD BILLION, THOUSAND UNITS), 2020-2030
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
Â
- BAXTER INTERNATIONAL INC.
- RL SOLUTIONS
- TRUVEN HEALTH ANALYTICS (AN IBM COMPANY)
- DEB GROUP LTD.
- HYGREEN, INC.
- ATLAS MEDICAL SOFTWARE
- BECTON, DIKINSON AND COMPANY
- PREMIER INC.
- WOLTERS KLUWER N.V.
- GOJO INDUSTRIES, INC. *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 2Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 3Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 4Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 5Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 6Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 7Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY REGION (USD BILLION), 2020-2030
TABLE 8Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY REGION (THOUSAND UNITS), 2020-2030
TABLE 9Â Â Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS BY COUNTRY (USD BILLION), 2020-2030
TABLE 10Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS BY COUNTRY (THOUSAND UNITS), 2020-2030
TABLE 11Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 12Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 13Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 14Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 15Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 16Â Â Â NORTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER INDUSTRY (THOUSAND UNITS), 2020-2030
TABLE 17Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 18Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 19Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 20Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 21Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 22Â Â Â US INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 23Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 24Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 25Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 26Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 27Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 28Â Â Â CANADA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 29Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 30Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 31Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 32Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 33Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 34Â Â Â MEXICO INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 35Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 36Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2030
TABLE 37Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 38Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 39Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 40Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 41Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 42Â Â Â SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 43Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 44Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 45Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 46Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 47Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 48Â Â Â BRAZIL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 49Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 50Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 51Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 52Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 53Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 54Â Â Â ARGENTINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 55Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 56Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 57Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 58Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 59Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 60Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 61Â Â Â COLOMBIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 62Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 63Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 64Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 65Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 66Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 67Â Â Â REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 68Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 69Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2030
TABLE 70Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 71Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 72Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 73Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 74Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 75Â Â Â ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 76Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 77Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 78Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 79Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 80Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 81Â Â Â INDIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 82Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 83Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 84Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 85Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 86Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 87Â Â Â CHINA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 88Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 89Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 90Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 91Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 92Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 93Â Â Â JAPAN INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 94Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 95Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 96Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 97Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 98Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 99Â Â Â SOUTH KOREA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 100Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 101Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 102Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 103Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 104Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 105Â AUSTRALIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 106Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD MI LLION), 2020-2030
TABLE 107Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 108Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 109Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 110Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 111Â SOUTH EAST ASIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 112Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 113Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 114Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 115Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 116Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 117Â REST OF ASIA PACIFIC INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 118Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 119Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2030
TABLE 120Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 121Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 122Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 123Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 124Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 125Â EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 126Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 127Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 128Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 129Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 130Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 131Â GERMANY INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 132Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 133Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 134Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 135Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 136Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 137Â UK INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 138Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 139Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 140Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 141Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 142Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 143Â FRANCE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 144Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 145Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 146Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 147Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 148Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 149Â ITALY INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 150Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 151Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 152Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 153Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 154Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 155Â SPAIN INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 156Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 157Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 158Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 159Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 160Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 161Â RUSSIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 162Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 163Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 164Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 165Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 166Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 167Â REST OF EUROPE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 168Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 169Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2030
TABLE 170Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 171Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 172Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 173Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 174Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 175Â MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 176Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 177Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 178Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 179Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 180Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 181Â UAE INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 182Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 183Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 184Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 185Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 186Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 187Â SAUDI ARABIA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 188Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 189Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 190Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 191Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 192Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 193Â SOUTH AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
TABLE 194Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (USD BILLION), 2020-2030
TABLE 195Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT (THOUSAND UNITS), 2020-2030
TABLE 196Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (USD BILLION), 2020-2030
TABLE 197Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE (THOUSAND UNITS), 2020-2030
TABLE 198Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 199Â REST OF MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER (THOUSAND UNITS), 2020-2030
LIST OF FIGURESÂ Â Â Â Â Â Â Â Â Â Â Â Â
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT, USD BILLION, 2020-2030
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE, USD BILLION, 2020-2030
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER, USD BILLION, 2020-2030
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY COMPONENT, USD BILLION, 2022
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY DEPLOYMENT TYPE, USD BILLION, 2022
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY END USER, USD BILLION, 2022
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET BY REGION, USD BILLION, 2022
FIGURE 17Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â Â Â Â Â Â Â Â Â BAXTER INTERNATIONAL INC: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â Â Â Â RL SOLUTIONS: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â TRUVEN HEALTH ANALYTICS (AN IBM COMPANY): COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â DEB GROUP LTD: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â HYGREEN, INC: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â ATLAS MEDICAL SOFTWARE: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â BECTON, DIKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â PREMIER INC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â WOLTERS KLUWER N.V: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â GOJO INDUSTRIES, INC: COMPANY SNAPSHOT
FAQ
Infection surveillance solutions market is expected to grow at 13.9% CAGR from 2023 to 2030. It is expected to reach above USD 1.54 billion by 2030
North America held more than 40% of infection surveillance solutions market revenue share in 2022 and will witness expansion in the forecast period.
The global infection surveillance solutions market is being driven by a number of key factors, including an increase in the incidence of HAIs, an increase in the number of surgeries, the introduction of government protocols for the prevention of HAIs, an increase in global healthcare expenditure, the ease of use of the software system, and advancements in the healthcare insurance sectors.
By end user, the market is segmented into hospitals, clinics, ambulatory service centers, specialty centers, and others. A wide range of healthcare organizations, including hospitals, clinics, ambulatory service centers, specialty Centers, and others, are served by the market for infection surveillance solutions. Regulation requirements and rising patient demand have increased the need for infection control and prevention in these institutions, which has increased acceptance of these solutions and fueled the market expansion.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.